{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:11:24Z","timestamp":1781100684658,"version":"3.54.1"},"reference-count":50,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1684\/ejd.2017.3166","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:11:07Z","timestamp":1696864267000},"page":"3-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagnostic value of autoantibody titres in patients with bullous pemphigoid"],"prefix":"10.1684","volume":"28","author":[{"given":"Julia","family":"Eckardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska C.","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ghoreschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"3166_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E. Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D. Pemphigoid diseases. Lancet 2013; 381: 320\u201332.","journal-title":"Lancet"},{"key":"3166_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","volume":"41","author":"M. Jung","year":"1999","unstructured":"Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999; 41: 266\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"3166_CR3","first-page":"434","volume":"7","author":"F. Bertram","year":"2009","unstructured":"Bertram F, Brocker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009; 7: 434\u201340.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3166_CR4","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","volume":"132","author":"P. Joly","year":"2012","unstructured":"Joly P, Baricault S, Sparsa A, et al. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 2012; 132: 1998\u20132004.","journal-title":"J Invest Dermatol"},{"key":"3166_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1046\/j.1439-0353.2004.03642.x","volume":"2","author":"C. Sitaru","year":"2004","unstructured":"Sitaru C, Goebeler M, Zillikens D. Bullous autoimmune dermatoses (I): pathogenesis and diagnosis. J Dtsch Dermatol Ges 2004; 2: 123\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3166_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jim.2012.05.007","volume":"382","author":"J. Damoiseaux","year":"2012","unstructured":"Damoiseaux J, van Rijsingen M, Warnemunde N, Dahnrich C, Fechner K, Tervaert JW. Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS Dermatology Mosaic. J Immunol Methods 2012; 382: 76\u201380.","journal-title":"J Immunol Methods"},{"key":"3166_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2133.2009.09266.x","volume":"161","author":"C. Feliciani","year":"2009","unstructured":"Feliciani C, Caldarola G, Kneisel A, et al. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Br J Dermatol 2009; 161: 306\u201312.","journal-title":"Br J Dermatol"},{"key":"3166_CR8","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","volume":"176","author":"S. Thoma-Uszynski","year":"2006","unstructured":"Thoma-Uszynski S, Uter W, Schwietzke S, Schuler G, Borradori L, Hertl M. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006; 176: 2015\u201323.","journal-title":"J Immunol"},{"key":"3166_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.autrev.2011.07.002","volume":"11","author":"L.R. Zakka","year":"2011","unstructured":"Zakka LR, Reche P, Ahmed AR. Role of MHC Class II genes in the pathogenesis of pemphigoid. Autoimmuny Rev 2011; 11: 40\u20137.","journal-title":"Autoimmuny Rev"},{"key":"3166_CR10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S0738-081X(00)00194-2","volume":"19","author":"R.F. Ghohestani","year":"2001","unstructured":"Ghohestani RF, Novotney J, Chaudhary M, Agah RS. Bullous pemphigoid: from the bedside to the research laboratory. Clin Dermatol 2001; 19: 690\u20136.","journal-title":"Clin Dermatol"},{"key":"3166_CR11","first-page":"492","volume":"10","author":"N. van Beek","year":"2012","unstructured":"van Beek N, Knuth-Rehr D, Altmeyer P, et al. Diagnostics of autoimmune bullous diseases in German dermatology departments. J Dtsch Dermatol Ges 2012; 10: 492\u20139.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3166_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P. Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou JC, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002; 346: 321\u20137.","journal-title":"N Engl J Med"},{"key":"3166_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2133.1995.tb02631.x","volume":"133","author":"R.C. Beckers","year":"1995","unstructured":"Beckers RC, Brand A, Vermeer BJ, Boom BW. Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br J Dermatol 1995; 133: 289\u201393.","journal-title":"Br J Dermatol"},{"key":"3166_CR14","first-page":"833","volume":"13","author":"R. Eming","year":"2015","unstructured":"Eming R, Sticherling M, Hofmann SC, et al. S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 2015; 13: 833\u201344.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3166_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.clindermatol.2011.03.015","volume":"30","author":"D.A. Culton","year":"2012","unstructured":"Culton DA, Diaz LA. Treatment of subepidermal immunobullous diseases. Clin Dermatol 2012; 30: 95\u2013102.","journal-title":"Clin Dermatol"},{"key":"3166_CR16","first-page":"927","volume":"9","author":"A. Kneisel","year":"2011","unstructured":"Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy. J Dtsch Dermatol Ges 2011; 9: 927\u201347.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3166_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3109\/09537104.2013.784735","volume":"25","author":"E.N. Rifaioglu","year":"2014","unstructured":"Rifaioglu EN, Sen BB, Ekiz O, Dogramaci AC. Mean platelet volume and eosinophilia relationship in patients with bullous pemphigoid. Platelets 2014; 25: 264\u20137.","journal-title":"Platelets"},{"key":"3166_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","volume":"69","author":"M. Sardy","year":"2013","unstructured":"Sardy M, Kostaki D, Varga R, Peris K, Ruzicka T. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid. J Am Acad Dermatol 2013; 69: 748\u201353.","journal-title":"J Am Acad Dermatol"},{"key":"3166_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","volume":"10","author":"E. Schmidt","year":"2010","unstructured":"Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 2010; 10: 84\u20139.","journal-title":"Autoimmun Rev"},{"key":"3166_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/15665240113136660079","volume":"14","author":"J.V. Otten","year":"2014","unstructured":"Otten JV, Hashimoto T, Hertl M, Payne AS, Sitaru C. Molecular diagnosis in autoimmune skin blistering conditions. Curr Mol Med 2014; 14: 69\u201395.","journal-title":"Curr Mol Med"},{"key":"3166_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-4632.2008.03473.x","volume":"47","author":"S. Feng","year":"2008","unstructured":"Feng S, Wu Q, Jin P, et al. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Int J Dermatol 2008; 47: 225\u20138.","journal-title":"Int J Dermatol"},{"key":"3166_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5021\/ad.2012.24.1.45","volume":"24","author":"E.H. Lee","year":"2012","unstructured":"Lee EH, Kim YH, Kim S, Kim SE, Kim SC. Usefulness of enzymelinked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid. Ann Dermatol 2012; 24: 45\u201355.","journal-title":"Ann Dermatol"},{"key":"3166_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","volume":"7","author":"N. van Beek","year":"2012","unstructured":"van Beek N, Rentzsch K, Probst C, et al. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 2012; 7: 49.","journal-title":"Orphanet J Rare Dis"},{"key":"3166_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","volume":"16","author":"C. Sitaru","year":"2007","unstructured":"Sitaru C, Dahnrich C, Probst C, et al. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 2007; 16: 770\u20137.","journal-title":"Exp Dermatol"},{"key":"3166_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","volume":"41","author":"M. Yoshida","year":"2006","unstructured":"Yoshida M, Hamada T, Amagai M, et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 2006; 41: 21\u201330.","journal-title":"J Dermatol Sci"},{"key":"3166_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","volume":"132","author":"S. Bastuji-Garin","year":"1996","unstructured":"Bastuji-Garin S, Joly P, Picard-Dahan C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 1996; 132: 272\u20136.","journal-title":"Arch Dermatol"},{"key":"3166_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","volume":"149","author":"A. Lloyd-Lavery","year":"2013","unstructured":"Lloyd-Lavery A, Chi CC, Wojnarowska F, Taghipour K. The associations between bullous pemphigoid and drug use: a UKcase-control study. JAMA Dermatol 2013; 149: 58\u201362.","journal-title":"JAMA Dermatol"},{"key":"3166_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","volume":"131","author":"S. Bastuji-Garin","year":"2011","unstructured":"Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 2011; 131: 637\u201343.","journal-title":"J Invest Dermatol"},{"key":"3166_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","volume":"161","author":"G. Marazza","year":"2009","unstructured":"Marazza G, Pham HC, Scharer L, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 2009; 161: 861\u20138.","journal-title":"Br J Dermatol"},{"key":"3166_CR30","first-page":"564","volume":"20","author":"P. Courville","year":"2000","unstructured":"Courville P, Kupfer I, Gilbert D, Thomine E, Metayer J, Joly P. Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies. Ann Pathol 2000; 20: 564\u20139.","journal-title":"Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies. Ann Pathol"},{"key":"3166_CR31","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/bjd.14686","volume":"175","author":"S. Glauser","year":"2016","unstructured":"Glauser S, Rutz M, Cazzaniga S, Hegyi I, Borradori L, Beltraminelli H. Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid. Br J Dermatol 2016; 175: 988\u201393.","journal-title":"Br J Dermatol"},{"key":"3166_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1046\/j.1365-2230.2003.01419.x","volume":"28","author":"Y.C. Chan","year":"2003","unstructured":"Chan YC, Sun YJ, Ng PP, Tan SH. Comparison of immunofluorescence microscopy, immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid. Clin Exp Dermatol 2003; 28: 651\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"3166_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1034\/j.1600-0560.2002.290504.x","volume":"29","author":"K.E. Buschman","year":"2002","unstructured":"Buschman KE, Seraly M, Thong HY, Deng JS, Draviam RP, Abernethy JL. A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid. J Cutan Pathol 2002; 29: 282\u20136.","journal-title":"J Cutan Pathol"},{"key":"3166_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2310\/7750.2014.14004","volume":"18","author":"C. Sladden","year":"2014","unstructured":"Sladden C, Kirchhof MG, Crawford RI. Biopsy location for direct immunofluorescence in patients with suspected bullous pemphigoid impacts probability of a positive test result. J Cutan Med Surg 2014; 18: 392\u20136.","journal-title":"J Cutan Med Surg"},{"key":"3166_CR35","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/bjd.13717","volume":"172","author":"C. Feliciani","year":"2015","unstructured":"Feliciani C, Joly P, Jonkman MF, et al. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol 2015; 172: 867\u201377.","journal-title":"Br J Dermatol"},{"key":"3166_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1590\/abd1806-4841.20143221","volume":"89","author":"S.T. Arbache","year":"2014","unstructured":"Arbache ST, Nogueira TG, Delgado L, Miyamoto D, Aoki V. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience. An Bras Dermatol 2014; 89: 885\u20139.","journal-title":"An Bras Dermatol"},{"key":"3166_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0190-9622(83)70073-3","volume":"8","author":"L.L. Bushkell","year":"1983","unstructured":"Bushkell LL, Jordon RE. Bullous pemphigoid: a cause of peripheral blood eosinophilia. J Am Acad Dermatol 1983; 8: 648\u201351.","journal-title":"J Am Acad Dermatol"},{"key":"3166_CR38","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1365-4632.2008.03824.x","volume":"47","author":"M.A. Barnadas","year":"2008","unstructured":"Barnadas MA, Rubiales MV, Gonzalez MJ, et al. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis. Int J Dermatol 2008; 47: 1245\u20139.","journal-title":"Int J Dermatol"},{"key":"3166_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/1523-1747.ep12259692","volume":"82","author":"W.R. Gammon","year":"1984","unstructured":"Gammon WR, Briggaman RA, Inman AO3rd, Queen LL, Wheeler CE. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984; 82: 139\u201344.","journal-title":"J Invest Dermatol"},{"key":"3166_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","volume":"12","author":"M. Tampoia","year":"2012","unstructured":"Tampoia M, Giavarina D, Di Giorgio C, Bizzaro N. Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis. Autoimmun Rev 2012; 12: 121\u20136.","journal-title":"Autoimmun Rev"},{"key":"3166_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/ced.12510","volume":"40","author":"N. Esmaili","year":"2015","unstructured":"Esmaili N, Mortazavi H, Kamyab-Hesari K, et al. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid. Clin Exp Dermatol 2015; 40: 324\u201330.","journal-title":"Clin Exp Dermatol"},{"key":"3166_CR42","first-page":"74","volume":"146","author":"J.D. Fine","year":"2010","unstructured":"Fine JD. Prevalence of autoantibodies to bullous pemphigoid antigens within the normal population. Arch Dermatol 2010; 146: 74\u20135.","journal-title":"Arch Dermatol"},{"key":"3166_CR43","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","volume":"166","author":"I.M. Blocker","year":"2012","unstructured":"Blocker IM, Dahnrich C, Probst C, et al. Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol 2012; 166: 964\u201370.","journal-title":"Br J Dermatol"},{"key":"3166_CR44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","volume":"147","author":"J. Charneux","year":"2011","unstructured":"Charneux J, Lorin J, Vitry F, et al. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol 2011; 147: 286\u201391.","journal-title":"Arch Dermatol"},{"key":"3166_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.15114","volume":"177","author":"T. Hashimoto","year":"2017","unstructured":"Hashimoto T, Ohzono A, Teye K, et al. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid. Br J Dermatol 2017; 177: 141\u201351.","journal-title":"Br J Dermatol"},{"key":"3166_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1684\/ejd.2012.1901","volume":"23","author":"S. Bracke","year":"2013","unstructured":"Bracke S, Speeckaert R, Van Geel N, De Bacquer D, Lambert J. Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study. Eur J Dermatol 2013; 23: 33\u20139.","journal-title":"Eur J Dermatol"},{"key":"3166_CR47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/j.1468-3083.2011.04294.x","volume":"26","author":"V. Anand","year":"2012","unstructured":"Anand V, Khandpur S, Sharma VK, Sharma A. Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris. J Eur Acad Dermatol Venereol 2012; 26: 1377\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3166_CR48","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","volume":"19","author":"E. Schmidt","year":"2010","unstructured":"Schmidt E, Dahnrich C, Rosemann A, et al. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol 2010; 19: 458\u201363.","journal-title":"Exp Dermatol"},{"key":"3166_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamadermatol.2013.5757","volume":"150","author":"F. Fichel","year":"2014","unstructured":"Fichel F, Barbe C, Joly P, et al. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study. JAMA Dermatol 2014; 150: 25\u201333.","journal-title":"JAMA Dermatol"},{"key":"3166_CR50","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/0190-9622(90)70094-X","volume":"22","author":"W.R. Gammon","year":"1990","unstructured":"Gammon WR, Kowalewski C, Chorzelski TP, Kumar V, Briggaman RA, Beutner EH. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990; 22: 664\u201370.","journal-title":"J Am Acad Dermatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2017.3166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2017.3166\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2017.3166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2017.3166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:18:12Z","timestamp":1741191492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2017.3166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"alternative-id":["3166"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2017.3166","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,1]]},"assertion":[{"value":"3 Juli 2017","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}